Manufacturers Life Insurance Company, The Talaris Therapeutics, Inc. Transaction History

Manufacturers Life Insurance Company, The

  • $108 Billion
  • Q3 2024

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2022

Aug 11, 2023
BUY
$4.51 - $9.85 $45,650 - $99,701
10,122 New
10,122 $45,000
Q2 2022

Aug 15, 2022
BUY
$4.51 - $9.85 $45,650 - $99,701
10,122 New
10,122 $46,000
Q1 2022

May 20, 2022
SELL
$6.89 - $16.56 $74,205 - $178,351
-10,770 Closed
0 $0
Q4 2021

Feb 16, 2022
BUY
$12.18 - $17.0 $131,178 - $183,090
10,770 New
10,770 $165,000

Others Institutions Holding TALS

# of Institutions
3
Shares Held
75.7K
Call Options Held
0
Put Options Held
0
View Full List

About Talaris Therapeutics, Inc.

TALS Quotes by TradingView
  • Ticker TALS
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 39,995,900
  • Market Cap $109M
  • Description
  • Talaris Therapeutics, Inc. operates as a late-clinical stage cell therapy company in the United States. The company engages in developing a method of allogeneic hematopoietic stem cell transplantation to transform the standard of care in solid organ transplantation and severe autoimmune diseases, as well as severe non-malignant blood, immune, an...
More about TALS
Track This Portfolio

Track Manufacturers Life Insurance Company, The Portfolio

Follow Manufacturers Life Insurance Company, The and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Manufacturers Life Insurance Company, The, based on Form 13F filings with the SEC.

News

Stay updated on Manufacturers Life Insurance Company, The with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email